[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370479-105":59,"doc-detail-370479-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","human-papillomavirus-hpv-related-oropharyngeal-cancers-in-canada-a-multicenter-retrospective-cohort-study","Human papillomavirus (HPV) related oropharyngeal cancers in Canada - A multicenter retrospective cohort study","","Oral human papillomavirus (HPV) infection is a risk factor for oropharyngeal cancer (OPC), now the leading HPV-related cancer in males in Canada, and p16 positivity serves as a surrogate marker for HPV positivity. A retrospective chart review of 1,154 squamous cell OPC cases from 2016–2020 across four major Canadian hospital-based oncology centers estimated HPV attributable fraction using p16. Most patients were male and most tumors were p16 positive; p16 positivity associated with younger age, male sex, lower tumor stage, and never-smoking, with logistic regression confirming these links, supporting gender-neutral vaccination.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-papillomavirus-hpv-related-oropharyngeal-cancers-in-canada-a-multicenter-retrospective-cohort-study/370479/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-papillomavirus-hpv-related-oropharyngeal-cancers-in-canada-a-multicenter-retrospective-cohort-study/370479.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is p16 used in the study of HPV-related OPC?","Question",{"text":113,"@type":114},"P16 positivity is treated as a surrogate marker of HPV positivity, allowing attribution of OPC to HPV in the retrospective review.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the study conducted and which patients were included?",{"text":118,"@type":114},"Researchers reviewed medical charts of squamous cell OPC cases in patients aged 18 and older diagnosed from 2016 to 2020 across four major Canadian hospital-based regional oncology centers.",{"name":120,"@type":111,"acceptedAnswer":121},"What demographic and clinical factors were associated with p16 positivity?",{"text":122,"@type":114},"P16 positivity correlated with younger age, male sex, lower tumor stage, and a higher likelihood of never smoking; these associations were confirmed by logistic regression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370479,1790557077,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE     \nHuman papillomavirus (HPV) related oropharyngeal cancers in Canada: A multicenter retrospective cohort study  \nVoica Racovitana, Elizabeth Goodmanb, Winson Y. Cheungc, Anthony C. Nicholsd, Lisa Caulleye, and Sabrina Wurzbaf  \naGlobal Marketing HPV Strategy, Merck & Co. Inc ., North Wales, PA, USA; bVaccine Outcomes Research, Value and Implementation, Merck and Co., Inc., North Wales, PA, USA; cDepartments of Medicine and Oncology, University of Calgary and the Charbonneau Cancer Institute, Calgary, AB, Canada; dDepartment of Otolaryngology – Head and Neck Surgery, University of Western Ontario, London, ON, Canada; eOttawa Hospital Research Institute, Ottawa, ON, Canada; fDepartment of Otolaryngology – Head and Neck Surgery, McGill University and the Jewish General Hospital, Montreal, QC, Canada  \nABSTRACT  \nOral human papillomavirus (HPV) infection is a risk for oropharyngeal cancer (OPC), now the leading HPVrelated cancer in males in Canada. P16 positivity is a marker of HPV positivity. Since 2015, all major Canadian cancer centers perform routine p16 tumor marker testing of OPCs to define their HPV status but recent data on the HPV-attributable fraction for OPC in Canada do not exist. A retrospective chart review was conducted of all squamous cell OPC cases in patients 18 years and older diagnosed from 2016 to 2020 in 4 major Canadian hospital-based regional oncology centers to determine the HPV attributable fraction for OPC in Canada using p16 as a surrogate marker for HPV. 1154 OPC cases were identified. Most patients (85.4%) were male; about one-third 26 (31.4%) had never smoked. Most OPC (80.6%) were P16 positive. p16 positivity was 27 associated with younger age (mean age p16+ 61.6 vs. p16- 66.5 years, p \u003C 0.0001), male sex 28 (p16+ males 84.0% vs p16+ females 60.9%, p \u003C 0.0001), lower tumor stage (Stage 1 p16+ 29 88.1% vs Stage 4 p16+ 69.4%, p \u003C 0.001), and non-smoking (never smoked 92.3% vs past 30 smoker 82.8% vs current smoker 65.0%, p \u003C 0.001) . Logistic regression confirmed these 31 associations. This study, the largest cohort of Canadian patients with OPC yet reported, demonstrates the high attributable fraction for HPV-related OPC. HPV-related OPC was more likely in men, younger individuals, and never smokers. These findings highlight the burden of HPV-related OPC in Canada and support gender-neutral HPV vaccination as an important public health strategy to prevent head and neck cancer.  \nARTICLE HISTORY  \nReceived 17 January 2025 Revised 13 March 2025 Accepted 27 March 2025  \nKEYWORDS  \nHuman papillomavirus; oropharyngeal cancer; p16; risk factors; Canada  \nIntroduction  \nHead and neck squamous cell carcinomas (HNSCCs) are the sixth most common global cancer. 1,2 Their incidence, currently estimated at 890,000 new cases with 450,000 deaths per year, has risen substantially during the past two decades and is predicted to exceed 1 million new cases annually by 2030.3,4 Age-standardized rates are highest in high-income countries, including Canada, the USA and Oceana, and remain high due primarily to increasing oropharyngeal cancers (OPC), which arise from progenitor cells in the oropharynx, soft palate, tonsils and posterior one-third of the tongue.3,5 Age-standardized incidence rates of OPC are up to 5 times higher in males than in females, and Canadian cancer statistics indicate that the incidence of OPC in males is rapidly approaching, and will exceed, the rate of cervical cancer in females.6–9 Despite advances in therapy, including minimally invasive or transoral robotic resection, combinatorial radiotherapy and multidrug chemotherapy, and the emerging use of immunotherapy for checkpoint inhibition, 10 OPC imposesa high disease burden and outcomes are poor. Swallowing and speech impairment occur in approximately half of survivors, quality of life is often seriously diminished, and suicide is  \n11  \ncommon.  \nEpidemiological studies document multiple risk factors including genetic disorder","cbCaigBYhkTiIAUB","https://ap.wps.com/l/cbCaigBYhkTiIAUB","pdf",851507,"English","# Abstract\n# Keywords\n# Introduction\n# Article History","[{\"question\":\"Why is p16 used in the study of HPV-related OPC?\",\"answer\":\"P16 positivity is treated as a surrogate marker of HPV positivity, allowing attribution of OPC to HPV in the retrospective review.\"},{\"question\":\"How was the study conducted and which patients were included?\",\"answer\":\"Researchers reviewed medical charts of squamous cell OPC cases in patients aged 18 and older diagnosed from 2016 to 2020 across four major Canadian hospital-based regional oncology centers.\"},{\"question\":\"What demographic and clinical factors were associated with p16 positivity?\",\"answer\":\"P16 positivity correlated with younger age, male sex, lower tumor stage, and a higher likelihood of never smoking; these associations were confirmed by logistic regression.\"}]","Human papillomavirus (HPV) related oropharyngeal cancers in Canada - A multicenter retrospective cohort study | PDF",1790188737,18,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/729705f69273f5fb180b233528b7611e.webp",983,1280,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b54d68399f141ba4ee6dfaf668da2e6.webp",982,1278,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ceb82f290fe5f013c6e7bc864137309.webp",981,1277,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf1f629f16aa93e188a960479538f91f.webp",980,1276]